Please enable Javascript
Conferences
Partners
Expert Interviews
Subscribe
Breast Cancers Today
HER2 Breast Cancer
HR Breast Cancer
Triple-Negative Breast Cancer
Genetics & Breast Cancer
Gastro Today
Inflammatory Bowel Disease
Irritable Bowel Syndrome
Hepatitis
Heme Today
Anemia
Deep Vein Thrombosis
Essential Thrombocythemia
Hemophilia
Immune Thrombocytopenic Purpura
Myelodysplastic Syndromes
Myelofibrosis
Myeloproliferative Neoplasms
PNH
Polycythemia Vera
Pulmonary Embolism
Sickle Cell Disease
Thrombocytopenia
Thrombophilia
Thrombosis
Thrombotic Thrombocytopenic Purpura
Venous Thromboembolism
von Willebrand Disease
Metabolic Care Today
Diabetes
Obesity
Nephrology Times
Acute Kidney Injury
ADPKD
Anemia and Kidney Disease
Chronic Kidney Disease
COVID-19 and Kidney Disease
Diabetes and Hypertension
End-Stage Renal Disease
Gout
Hyperkalemia
IgAN
Kidney Transplantation
Metabolic Acidosis
Sleep
More
Career News
Future of Medicine
Health and Wellness
— HIV
Infectious Diseases
Lupus
Neurology
Oncology
Ophthalmology
— Demodex Blepharitis
Orthopedics
Pharmacology
Pulmonology
Rheumatology
Urology
Robert E. Merritt, MD, MBA, FACS
Articles by Robert E. Merritt, MD, MBA, FACS
Sublobar Resection in Early-Stage NSCLC: Thoracic Surgeon Shares Insights From New Research
Robert E. Merritt, MD, MBA, FACS
Non-Small Cell Lung Cancer
|
July 10, 2025
Dr. Merritt shares new thoracic surgery research insights for patient selection in sublobar resection for early-stage NSCLC.
View More
Clinical Considerations Surrounding Sublobar Resection in NSCLC: Dr. Merritt Discusses Recent Review
Robert E. Merritt, MD, MBA, FACS
Non-Small Cell Lung Cancer
|
July 10, 2025
Robert E. Merritt, MD, MBA, FACS, shares insights on his systematic review of sublobar resection and lobectomy.
View More
Dr. Merritt on the Prognostic Value of SUVmax Change in the LCMC3 Study
Robert E. Merritt, MD, MBA, FACS
WCLC 2024
|
October 2, 2024
Robert E. Merritt, MD, MBA, FACS, discusses the analysis he presented at the IASLC 2024 World Conference on Lung Cancer.
View More